RESPIRATORY

We are committed to advancing the diagnosis, treatment, and management of respiratory and sleep-related disorders through high-quality, evidence-driven clinical research. Chronic respiratory diseases and sleep disorders affect millions worldwide, significantly impacting quality of life and increasing the burden on healthcare systems. Our work supports the development of innovative therapeutics, devices, and diagnostic tools to address these complex conditions.

We collaborate with leading pulmonologists, sleep specialists, and academic centers to conduct trials that meet global regulatory standards while prioritizing patient safety and comfort.

respiratory

Core Research Areas:

Respiratory Disorders:
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma (Adult and Pediatric)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Interstitial Lung Disease (ILD)
  • Pulmonary Arterial Hypertension (PAH)
  • Cystic Fibrosis
  • Acute Respiratory Infections – including influenza, RSV, and COVID-19
  • Tuberculosis and MDR-TB
  • Lung Cancer Supportive Therapies
Sleep Medicine Disorders:
  • Obstructive Sleep Apnea (OSA)
  • Insomnia
  • Restless Leg Syndrome (RLS)
  • Narcolepsy
  • Circadian Rhythm Disorders
  • Hypersomnia and Sleep-Related Breathing Disorders

Research Capabilities at Tupalin Research:

  • Access to specialized respiratory and sleep clinics equipped with PFT labs, spirometry, and polysomnography (PSG)
  • Home sleep testing integration and wearable technology trials
  • Validated assessment tools such as ESS, PSQI, ACQ, ACT, and CAT scores
  • Central Laboratory Services for biomarker, inflammatory, and allergen panels
  • Electronic Data Capture (EDC) for symptom tracking, device performance, and longitudinal data
  • IVRS/IWRS Systems for enrollment and intervention logistics
  • CTMS for efficient trial management and regulatory compliance

Our Approach:

Our respiratory and sleep medicine studies are designed to meet the real-world needs of both patients and clinicians. We focus on inclusive, adaptive trial designs that leverage modern diagnostics and patient-reported outcomes to guide the development of better therapies.

With a commitment to scientific excellence and patient-centered care, we’re helping to breathe new life into clinical innovation—one discovery at a time.